GAVI Funds To Provide Fast Access To Money For Next Outbreak
According to Chief Executive Seth Berkley of the global vaccination alliance GAVI, the organisation has set up financial structures that would enable it to...
Forma Therapeutics To Be Acquired By Novo Nordisk For $1.1bn
On September 1, 2022, Novo Nordisk and Forma Therapeutics revealed that Novo Nordisk would buy Forma Therapeutics for for $1.1 billion. With the purchase...
CRISIL Expects Indian Pharma Sales To Climb 7%-9% In FY23
Due to challenges in export sales in the regulated markets and a large base effect in the home formulations sector, the Indian pharmaceutical industry...
Vaccine Cos Brace For Busy Months As Fear Of Influenza Looms
Flu season is just around the horizon as the summer draws to a close and fall looms. Influenza still poses a threat, and leading...
ViiV Sets Up A $500,000 Monkeypox Fund As Emergency Response
In a press statement, ViiV Healthcare stated that the Monkeypox Emergency Response Fund would be distributed to U.S. community-based organisations.
ViiV, which has a strong...
How The Pharmaceutical Sector Is Striving To Cut Emissions?
As competing businesses rushed to deliver the first COVID-19 vaccine starting in early 2020, the pharmaceutical sector has been in the press more than...
Europe To Obtain 85 Million Pandemic Flu Vaccines From GSK
Adjupanrix, a pandemic influenza vaccine (split virion, inactivated, adjuvanted) manufactured by GSK, has been reserved for future manufacturing and supply under a framework agreement with...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...